Sebastian Böttcher
14PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Aug 28, 2025
Long-Term Immune Response to SARS-CoV-2 Vaccination in Hematologic Malignancies: An Update of the ImV-HOng Trial of the East German Study Group for Hematology and Oncology.Susann Schulze, Sabrina Jotschke, Robby Engelmann
|Aug 30, 2024
End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia.Florian Simon, Rudy Ligtvoet, Sandra Robrecht
|Apr 15, 2024
Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial.Moritz Fürstenau, Adam Giza, Jonathan Weiss
|Jan 30, 2024
Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemia.Stephan Stilgenbauer, Eugen Tausch, Andrew W Roberts
|Jun 26, 2023
Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut.Henriette Huber, Eugen Tausch, Christof Schneider
|Mar 22, 2023
Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia.Robby Engelmann, Nadja Jaekel, Sabrina Jotschke
Pageof 3
Frequent Collaborators
5 joint publications
Moritz Fürstenau
4 joint publications
Robby Engelmann
3 joint publications
Frank Bernhard Kraus
3 joint publications
Carsten U Niemann
3 joint publications
Nadja Jaekel
3 joint publications
Susann Schulze
3 joint publications
Beatrice Ludwig-Kraus
2 joint publications
Eugen Tausch
2 joint publications
Joana Caetano
2 joint publications
Juan Flores-Montero
